If you have information relating to this investigation and/or investment losses with Nano-X Imaging Ltd. (NNOX), contact Silver Law Group for a no cost consultation at (800) 975-4345 or by email at ssilver@silverlaw.com.
Nano-X Imaging Ltd. (NNOX) is a company based in Israel that develops and produces X-ray technology for medical imaging.
On September 15, 2020, Citron Research released a report with the title “Nano-X (NNOX) A Complete Farce on the Market.” The Citron report described problems with the company, and stated that “this $3 billion company is nothing more than a science project with a simple rendering minimal R&D, fake customers, no FDA approval, and fraudulent claims that are beyond the realm of possibility.”
After the Citron report was published, Nano-X’s stock fell almost 23%, causing losses for investors.
Nano-X Imaging Ltd. (NNOX) held its initial public offering (IPO) in August, 2020, and trades on the Nasdaq Global Market. Cantor Fitzgerald & Co., Oppenheimer & Co. Inc., and Berenberg and CIBC Capital Markets were joint book-runners for the offering. National Securities Corporation was co-manager for the offering.
Recovering Nano-X Imaging Ltd. (NNOX) Investment Losses
If you have investment losses with Nano-X Imaging Ltd. (NNOX), contact Silver Law Group, a nationally-recognized class action law firm representing investors, to discuss your options to recover your losses.
Silver Law Group represents victims of investment fraud. Our attorneys represent investors in class actions against issuers in state or federal court and investors in securities arbitration claims against Wall Street firms for stockbroker misconduct.
Scott Silver, Silver Law Group’s managing partner, is the chairman of the Securities and Financial Fraud Group of the American Association of Justice. Contact us today for a no-cost consultation at ssilver@silverlaw.com or toll free at (800) 975-4345.